Health Canada drug identification number

DIN 02454696 — SPC-FENOFIBRATE E 145 MG

SPC-FENOFIBRATE E is a tablet of Fenofibrate marketed by SUN PHARMA CANADA INC. The full Fenofibrate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02454696
Brand name
SPC-FENOFIBRATE E
Active ingredient
Fenofibrate
Strength
145 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
SUN PHARMA CANADA INC
Health Canada status
MARKETED
Drug class
Fibric acid derivative (fibrate) lipid metabolism regulator

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Fenofibrate products

DINBrandStrengthFormManufacturerStatus
02239864 AA-FENO-MICRO 200 MG CAPSULE AA PHARMA INC MARKETED
02243180 AA-FENO-MICRO 67 MG CAPSULE AA PHARMA INC MARKETED
02246859 AA-FENO-SUPER 100 MG TABLET AA PHARMA INC MARKETED
02246860 AA-FENO-SUPER 160 MG TABLET AA PHARMA INC MARKETED
02225980 FENOFIBRATE 100 MG CAPSULE AA PHARMA INC DORMANT
02269082 LIPIDIL EZ 145 MG TABLET BGP PHARMA ULC MARKETED
02269074 LIPIDIL EZ 48 MG TABLET BGP PHARMA ULC MARKETED
02241602 LIPIDIL SUPRA 160 MG TABLET BGP PHARMA ULC MARKETED
02273551 PMS-FENOFIBRATE MICRO 200 MG CAPSULE PHARMASCIENCE INC DORMANT
02390701 SANDOZ FENOFIBRATE E 145.0 MG TABLET SANDOZ CANADA INCORPORATED MARKETED
02390698 SANDOZ FENOFIBRATE E 48.0 MG TABLET SANDOZ CANADA INCORPORATED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.